Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at the 22nd Annual Piper Jaffray Health Care Conference

BOULDER, Colo., Nov 16, 2010 (BUSINESS WIRE) --

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 22nd Annual Piper Jaffray Health Care Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.


22nd Annual Piper Jaffray Health Care Conference


Robert E. Conway, Chief Executive Officer, Array BioPharma


Tuesday, November 30, 2010


3:00 p.m. Eastern Time


The New York Palace, NYC


About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to

SOURCE: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193